thiO Resolved · high auto-curated

H37Rv Rv0415 · MTBC0 mtbc0_000435 · 340 aa · 504513–505535 MTBC0 (+) · RefSeq NP_214929.1

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)thiamine biosynthesis oxidoreductase ThiO
MTBC0 PGAP re-annotationglycine oxidase ThiO
Revised (this work)Glycine oxidase ThiO. Pfam: DAO (PF01266.31).
Functional category (TubercuList)intermediary metabolism and respiration

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) 87 publications

87 TB publications mention this gene. 87 publications discuss this gene. Queried separately, 71 records carry a M. tuberculosis context and 11 a non-TB mycobacterial context (species named in the 11-record verified sample: M. smegmatis (8), M. abscessus (1), M. leprae (1), M. marinum (1)). The three counts come from three distinct PubMed queries (each with its own context filter), so they neither partition the total nor need to add up to it.

5 of 87: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
Super-Armed Thiomannopyranosides in the Synthesis of a Mannose-Capped Trisaccharide of Mycobacterium tuberculosis Lipoarabinomannan. doi:10.3390/molecules31101598 2026
QSAR-based drug discovery of 2-((4-Imino-3,4-dihydroquinazolin-2-yl)thio-substituted analogs targeting Mycobacterium tuberculosis. doi:10.1016/j.bmc.2026.118572 2026
5-Substituted 4-Thiouridines, 4-Thio-2'-deoxyuridines and Their Oligoglycol Carbonate Prodrugs as Promising Antimicrobial Agents. doi:10.3390/ijms262311712 2025
Synthesis of S- or N-glycomimetics of D-galactono-1,4-lactone: inhibitors of a β-galactofuranosidase. doi:10.1039/d5ob01674f 2026
Crystal structure, Hirshfeld surface, DFT and mol-ecular docking studies of 2-{4-[(E)-(4-acetylphen-yl)diazen-yl]phen-yl}-1-(5-bromo-thio-phen-2-yl)ethanone; a compound with bromine⋯oxygen-type contacts. doi:10.1107/S2056989024010776 2024
99 records returned by the alias sweep (a separate sweep from the 87 above; both are shown, neither is exhaustive)

Searched as: Rv0415, thiO, Mb0423, ML0299c, MMAR_0718, MSMEG_0791, MAB_4218c — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

PublicationJournalYear
Design, synthesis and antitubercular evaluation of novel 5,6-diphenyl-1,2,4-triazine-piperazine derivatives targeting mycobacterial dihydrofolate reductase. doi:10.5599/admet.3322 ADMET DMPK 2026
MTK_MCPA: A novel magnesium-competitive inhibitor of Mycobacterium tuberculosis thymidylate kinase. doi:10.1016/j.jmgm.2026.109519 J Mol Graph Model 2026
Super-Armed Thiomannopyranosides in the Synthesis of a Mannose-Capped Trisaccharide of Mycobacterium tuberculosis Lipoarabinomannan. doi:10.3390/molecules31101598 Molecules 2026
QSAR-based drug discovery of 2-((4-Imino-3,4-dihydroquinazolin-2-yl)thio-substituted analogs targeting Mycobacterium tuberculosis. doi:10.1016/j.bmc.2026.118572 names it Bioorg Med Chem 2026
Synthesis of S- or N-glycomimetics of D-galactono-1,4-lactone: inhibitors of a β-galactofuranosidase. doi:10.1039/d5ob01674f Org Biomol Chem 2026
5-Substituted 4-Thiouridines, 4-Thio-2'-deoxyuridines and Their Oligoglycol Carbonate Prodrugs as Promising Antimicrobial Agents. doi:10.3390/ijms262311712 names it Int J Mol Sci 2025
Enhancing the antimycobacterial efficacy of pyridine-4-carbohydrazide: linkage to additional antimicrobial agents via oxocarboxylic acids. doi:10.1039/d4md00663a RSC Med Chem 2025
Crystal structure, Hirshfeld surface, DFT and mol-ecular docking studies of 2-{4-[(E)-(4-acetylphen-yl)diazen-yl]phen-yl}-1-(5-bromo-thio-phen-2-yl)ethanone; a compound with bromine⋯oxygen-type contacts. doi:10.1107/S2056989024010776 names it Acta Crystallogr E Crystallogr Commun 2024
Discovery, Synthesis, and Optimization of 1,2,4-Triazolyl Pyridines Targeting Mycobacterium tuberculosis. doi:10.1021/acsinfecdis.3c00341 ACS Infect Dis 2023
Synthesis and pharmacological evaluation of 1,3-diaryl substituted pyrazole based (thio)urea derivatives as potent antimicrobial agents against multi-drug resistant Staphylococcus aureus and Mycobacterium tuberculosis. doi:10.1039/d3md00079f names it RSC Med Chem 2023
Synthesis and antitubercular activity of novel 4-arylalkyl substituted thio-, oxy- and sulfoxy-quinoline analogues targeting the cytochrome bc1 complex. doi:10.1016/j.bioorg.2023.106659 names it Bioorg Chem 2023
Putative volatile biomarkers of bovine tuberculosis infection in breath, skin and feces of cattle. doi:10.1007/s11010-023-04676-5 Mol Cell Biochem 2023
Non-amplification nucleic acid detection with thio-NAD cycling. doi:10.1016/j.mimet.2022.106647 names it J Microbiol Methods 2023
Serum Interleukin 6 Level and Nutrition Status as Potential Predictors of Clinical Leprosy Development Among Household Contacts in Endemic Areas. doi:10.1093/ofid/ofac010 Open Forum Infect Dis 2022
Pediatric Leprosy Profile in the Postelimination Era: A Study from Surabaya, Indonesia. doi:10.4269/ajtmh.21-0458 Am J Trop Med Hyg 2022
Novel 2,4-disubstituted quinazoline analogs as antibacterial agents with improved cytotoxicity profile: Optimization of the 2,4-substituents. doi:10.1016/j.bioorg.2021.105422 Bioorg Chem 2021
Teaching an old dog new tricks: repurposing β-lactams. doi:10.1016/j.tips.2021.06.003 Trends Pharmacol Sci 2021
N-Thio-β-lactams targeting L,D-transpeptidase-2, with activity against drug-resistant strains of Mycobacterium tuberculosis. doi:10.1016/j.chembiol.2021.03.008 names it Cell Chem Biol 2021
Recent advances in drug discovery against Mycobacterium tuberculosis: Metal-based complexes. doi:10.1016/j.ejmech.2021.113166 Eur J Med Chem 2021
2-((3,5-Dinitrobenzyl)thio)quinazolinones: Potent Antimycobacterial Agents Activated by Deazaflavin (F(420))-Dependent Nitroreductase (Ddn). doi:10.1021/acs.jmedchem.0c01374 names it J Med Chem 2021
A novel, rapid (within hours) culture-free diagnostic method for detecting live Mycobacterium tuberculosis with high sensitivity. doi:10.1016/j.ebiom.2020.103007 EBioMedicine 2020
[2-Chloro-3-nitro-5-(tri-fluoro-meth-yl)phen-yl](piperidin-1-yl)methanone: structural characterization of a side product in benzo-thia-zinone synthesis. doi:10.1107/S2056989020010658 Acta Crystallogr E Crystallogr Commun 2020
Discovery and evaluation of new compounds targeting ribosomal protein S1 in antibiotic-resistant Mycobacterium Tuberculosis. doi:10.1016/j.ejmech.2020.112317 Eur J Med Chem 2020
PPE51 Is Involved in the Uptake of Disaccharides by Mycobacterium tuberculosis. doi:10.3390/cells9030603 Cells 2020
Evaluation of Thio- and Seleno-Acetamides Bearing Benzenesulfonamide as Inhibitor of Carbonic Anhydrases from Different Pathogenic Bacteria. doi:10.3390/ijms21020598 names it Int J Mol Sci 2020
Synthesis of novel Schiff bases and azol-β-lactam derivatives starting from morpholine and thiomorpholine and investigation of their antitubercular, antiurease activity, acethylcolinesterase inhibition effect and antioxidant capacity. doi:10.1016/j.bioorg.2019.102928 Bioorg Chem 2019
Design, synthesis and in silico study of pyridine based 1,3,4-oxadiazole embedded hydrazinecarbothioamide derivatives as potent anti-tubercular agent. doi:10.1016/j.compbiolchem.2019.03.002 Comput Biol Chem 2019
Novel 5-substituted derivatives of 2'-deoxy-6-azauridine with antibacterial activity. doi:10.1038/s41429-019-0158-z J Antibiot (Tokyo) 2019
Acridine-based (thio)semicarbazones and hydrazones: Synthesis, in vitro urease inhibition, molecular docking and in-silico ADME evaluation. doi:10.1016/j.bioorg.2018.09.032 names it Bioorg Chem 2019
ATP hydrolysis-coupled peptide translocation mechanism of Mycobacterium tuberculosis ClpB. doi:10.1073/pnas.1810648115 Proc Natl Acad Sci U S A 2018
Transition State Analogue Inhibitors of 5'-Deoxyadenosine/5'-Methylthioadenosine Nucleosidase from Mycobacterium tuberculosis. doi:10.1021/acs.biochem.7b00576 Biochemistry 2017
Biosynthesis of isonitrile lipopeptides by conserved nonribosomal peptide synthetase gene clusters in Actinobacteria. doi:10.1073/pnas.1705016114 Proc Natl Acad Sci U S A 2017
Synthesis, biological evaluation, and molecular docking studies of novel 3-aryl-5-(alkyl-thio)-1H-1,2,4-triazoles derivatives targeting Mycobacterium tuberculosis. doi:10.1111/cbdd.13040 names it Chem Biol Drug Des 2017
Evaluation of the Mycobactericidal Effect of Thio-functionalized Carbohydrate Derivatives. doi:10.3390/molecules22050812 names it Molecules 2017
6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]thiazoles: Facile synthesis and comparative appraisal against tuberculosis and neglected tropical diseases. doi:10.1016/j.bmcl.2017.03.069 Bioorg Med Chem Lett 2017
Soil-transmitted helminth infections and leprosy: a cross-sectional study of the association between two major neglected tropical diseases in Indonesia. doi:10.1186/s12879-016-1593-0 BMC Infect Dis 2016
Mechanistic studies of a novel C-S lyase in ergothioneine biosynthesis: the involvement of a sulfenic acid intermediate. doi:10.1038/srep11870 Sci Rep 2015
Rifampin induces hydroxyl radical formation in Mycobacterium tuberculosis. doi:10.1128/AAC.03169-14 Antimicrob Agents Chemother 2014
Synthesis and biological activity of new salicylanilide N,N-disubstituted carbamates and thiocarbamates. doi:10.1016/j.bmc.2014.05.064 Bioorg Med Chem 2014
Mycobacterium tuberculosis type II NADH-menaquinone oxidoreductase catalyzes electron transfer through a two-site ping-pong mechanism and has two quinone-binding sites. doi:10.1021/bi4013897 Biochemistry 2014
Probing the amino acids critical for protein oligomerisation and protein-nucleotide interaction in Mycobacterium tuberculosis PII protein through integration of computational and experimental approaches. doi:10.1016/j.bbapap.2013.10.006 Biochim Biophys Acta 2013
6-Oxo and 6-thio purine analogs as antimycobacterial agents. doi:10.1016/j.bmc.2013.01.054 names it Bioorg Med Chem 2013
β-D-Arabinosyl 1-C-sulfonic acid(). doi:10.1080/17415993.2012.706814 J Sulphur Chem 2013
Mucosal adjuvanticity of fibronectin-binding peptide (FBP) fused with Echinococcus multilocularis tetraspanin 3: systemic and local antibody responses. doi:10.1371/journal.pntd.0001842 PLoS Negl Trop Dis 2012
Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors. doi:10.1016/j.bmc.2012.05.004 Bioorg Med Chem 2012
Nonprocessive [2 + 2]e- off-loading reductase domains from mycobacterial nonribosomal peptide synthetases. doi:10.1073/pnas.1118680109 Proc Natl Acad Sci U S A 2012
Circulating phospholipase-A2 activity in obstructive sleep apnea and recurrent tonsillitis. doi:10.1016/j.ijporl.2011.12.026 Int J Pediatr Otorhinolaryngol 2012
Synthesis and inhibitory activity of thymidine analogues targeting Mycobacterium tuberculosis thymidine monophosphate kinase. doi:10.1016/j.bmc.2011.10.021 Bioorg Med Chem 2011
C4-alkylthiols with activity against Moraxella catarrhalis and Mycobacterium tuberculosis. doi:10.1016/j.bmc.2011.09.030 Bioorg Med Chem 2011
The structure-antituberculosis activity relationships study in a series of 5-aryl-2-thio-1,3,4-oxadiazole derivatives. doi:10.1016/j.bmc.2011.09.038 names it Bioorg Med Chem 2011
Synthesis and structure-activity relationships of novel substituted 8-amino, 8-thio, and 1,8-pyrazole congeners of antitubercular rifamycin S and rifampin. doi:10.1016/j.bmcl.2011.08.054 names it Bioorg Med Chem Lett 2011
Planarity of heteroaryldithiocarbazic acid derivatives showing tuberculostatic activity. III. Mono- and diesters of 3-(pyrazin-2-ylcarbonyl)dithiocarbazic acid. doi:10.1107/S0108270111021767 Acta Crystallogr C 2011
Pitucamycin: structural merger of a phenoxazinone with an epoxyquinone antibiotic. doi:10.1021/np100344u J Nat Prod 2010
Conjugates of plumbagin and phenyl-2-amino-1-thioglucoside inhibit MshB, a deacetylase involved in the biosynthesis of mycothiol. doi:10.1016/j.bmc.2010.02.049 Bioorg Med Chem 2010
2,4-Diamino-5-methyl-6-substituted arylthio-furo[2,3-d]pyrimidines as novel classical and nonclassical antifolates as potential dual thymidylate synthase and dihydrofolate reductase inhibitors. doi:10.1016/j.bmc.2009.11.029 Bioorg Med Chem 2010
Synthesis of new 2-thio-[1,2,4]triazolo[1,5-c]quinazoline derivatives and its antimicrobial activity. doi:10.1248/cpb.57.580 names it Chem Pharm Bull (Tokyo) 2009
Effect of tuberculosis on the survival of HIV-infected men in a country with low tuberculosis incidence. doi:10.1097/QAD.0b013e32830e010c AIDS 2008
Synthesis and evaluation of antitubercular activity of glycosyl thio- and sulfonyl acetamide derivatives. doi:10.1016/j.bmcl.2008.06.004 names it Bioorg Med Chem Lett 2008
Synthesis of methyl 5-S-alkyl-5-thio-D-arabinofuranosides and evaluation of their antimycobacterial activity. doi:10.1016/j.bmc.2008.03.062 names it Bioorg Med Chem 2008
Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides. doi:10.1021/jm070391t J Med Chem 2007
Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B. doi:10.1097/QAD.0b013e32814e6b08 AIDS 2007
Synthesis of novel 5-aryl-2-thio-1,3,4-oxadiazoles and the study of their structure-anti-mycobacterial activities. doi:10.1016/j.bmc.2005.05.011 names it Bioorg Med Chem 2005
Electron transfer kinetics and mechanistic study of the thionicotinamide coordinated to the pentacyanoferrate(III)/(II) complexes: a model system for the in vitro activation of thioamides anti-tuberculosis drugs. doi:10.1016/j.jinorgbio.2004.10.004 J Inorg Biochem 2005
Synthesis of some 3-(arylalkylthio)-4-alkyl/aryl-5-(4-aminophenyl)-4H-1,2,4-triazole derivatives and their anticonvulsant activity. doi:10.1016/j.farmac.2004.07.005 Farmaco 2004
Antituberculosis agents X. Synthesis and evaluation of in vitro antituberculosis activity of 2-(5-nitro-2-furyl)- and 2-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,3,4-thiadiazole derivatives. doi:10.1007/BF02980122 Arch Pharm Res 2004
Antimycobacterial agents. 1. Thio analogues of purine. doi:10.1021/jm030389b names it J Med Chem 2004
Molecular characterization of dioxygenases from polycyclic aromatic hydrocarbon-degrading Mycobacterium spp. doi:10.1016/S0378-1097(03)00328-8 FEMS Microbiol Lett 2003
Metal ion-catalyzed nucleic acid alkylation and fragmentation. doi:10.1021/ja017746x J Am Chem Soc 2002
Synthesis and biological activity of 4-substituted 1-[1-(2-hydroxyethoxy)-methyl-1,2,3-triazol-(4 & 5)-ylmethyl]-1H-pyrazolo[3,4-d]pyrimidines. doi:10.1081/NCN-100107191 Nucleosides Nucleotides Nucleic Acids 2001
Mycobacterium tuberculosis lipoamide dehydrogenase is encoded by Rv0462 and not by the lpdA or lpdB genes. doi:10.1021/bi010575o Biochemistry 2001
Efficient, diastereoselective chemical synthesis of a beta-mannopyranosyl phosphoisoprenoid. doi:10.1021/ol006725p Org Lett 2000
Expression, purification, and characterization of Mycobacterium tuberculosis mycothione reductase. doi:10.1021/bi991025h Biochemistry 1999
Synthesis of p-trifluoroacetamidophenyl (4,6-dideoxy-4-formamido-3-C-methyl-2-O-methyl-alpha-L-mannopyranosyl)- (1-->3)-(2-O-methyl-alpha-D-rhamnopyranosyl)-(1-->3)- (2-O-methyl-alpha-L-fucopyranosyl)-(1-->3)-(alpha-L-rhamnopyranosyl)- (1-->2)-6-deoxy-alpha-L-talopyranoside: a spacer-armed pentasaccharide glycopeptidolipid antigen of Mycobacterium avium serovar 14. doi:10.1016/s0008-6215(98)00074-3 Carbohydr Res 1998
Postoperative abnormal prothrombinemia in patients with cefoperazone: report of two cases. doi:10.1007/s005950050113 Surg Today 1998
Evaluation of antimycobacterial and anticonvulsant activities of new 1-(4-fluorobenzoyl)-4-substituted-thiosemicarbazide and 5-(4-fluorophenyl)-4-substituted-2,4-dihydro-3H-1,2,4-triazole-3-thione derivatives. Farmaco 1997
Synthesis of a pentasaccharide fragment of Polysaccharide II of Mycobacterium tuberculosis. doi:10.1016/0008-6215(95)00199-4 Carbohydr Res 1995
Antimicrobial activity of 9-oxo and 9-thio acridines: correlation with interacalation into DNA and effects on macromolecular biosynthesis. doi:10.1016/0923-2508(96)80272-5 names it Res Microbiol 1995
Synthesis of 5-aminopentyl mono- to tri-saccharide haptens related to the species-specific glycopeptidolipids of Mycobacterium avium-intracellulare serovars 8 and 21. doi:10.1016/0008-6215(94)80062-6 Carbohydr Res 1994
Synthesis of p-trifluoroacetamidophenyl 6-deoxy-2-O-(3-O-[2-O-methyl-3-O- (2-O-methyl-alpha-D-rhamnopyranosyl)-alpha-L-fucopyranosyl]-alpha-L- rhamnopyranosyl)-alpha-L-talopyranoside: a spacer armed tetrasaccharide glycopeptidolipid antigen of Mycobacterium avium serovar 20. doi:10.1016/0008-6215(93)80060-r Carbohydr Res 1993
Effects of monomethylfumarate on human granulocytes. doi:10.1111/1523-1747.ep12358715 J Invest Dermatol 1993
A new approach to the chemical synthesis of the trisaccharide, and the terminal di- and mono-saccharide units of the major, serologically active glycolipid from Mycobacterium leprae. doi:10.1016/0008-6215(93)80099-z Carbohydr Res 1993
Iodonium ion-assisted synthesis of a haptenic tetrasaccharide fragment corresponding to the inner cell-wall glycopeptidolipid of Mycobacterium avium serotype 4. doi:10.1016/0008-6215(93)80102-k Carbohydr Res 1993
Isothermal in vitro amplification of DNA by a restriction enzyme/DNA polymerase system. doi:10.1073/pnas.89.1.392 Proc Natl Acad Sci U S A 1992
[Antitubercular agents. LIV. 3-Alkyl(or -alkyl) thio-2,5-pyrazindicarboxamides]. names it Cesk Farm 1991
In vivo-activated mononuclear phagocytes and protective immunity to chlamydiae in mice. doi:10.1128/iai.56.6.1492-1499.1988 Infect Immun 1988
Synthesis of the tetrasaccharide core region of antigenic lipo-oligosaccharides characteristic of Mycobacterium kansasii. doi:10.1016/0008-6215(88)84146-6 Carbohydr Res 1988
Structural requirements of muramylpeptides for induction of necrosis at sites primed with Mycobacterium tuberculosis in guinea pigs. doi:10.1128/iai.55.5.1279-1288.1987 Infect Immun 1987
Enzymatic synthesis, characterization, and metabolism of the coenzyme A ester of o-succinylbenzoic acid, an intermediate in menaquinone (vitamin K2) biosynthesis. J Biol Chem 1982
Some new 2-substituted thio 5-(4'-pyridyl)-1,3,4-oxadiazoles as possible antitubercular compounds. names it Pol J Pharmacol Pharm 1981
[Clinical trials of D. A. T.(4,4'-di-iso-amyloxy-thio-carbanilide) in common human pulmonary tuberculosis]. names it Rev Tuberc Pneumol (Paris) 1966
[ON THE EFFECTS OF THIO-TEPA ON EXPERIMENTAL TUBERCULOSIS]. names it Nagasaki Igakkai Zasshi 1964
[PREVENTION OF THE RECURRENCE OF CANCER]. Chiryo 1964
[HISTOCHEMICAL CHANGES IN PROTEIN THIO GROUPS DURING VARIOUS PHASES OF TUBERCULOUS INFLAMMATION]. names it Probl Tuberk 1963
Taste sensitivity to phenyl-thio-urea in tuberculosis and diabetes mellitus. doi:10.1111/j.1469-1809.1959.tb01469.x names it Ann Hum Genet 1959
[Demonstration of untoward effects of thiosemicarbazone therapy upon the liver in tuberculosis]. Tuberkulosearzt 1951
[The thiosemicarbazones]. J Med Bord 1951
[Comparison of the effect of streptomycin with thio-semicarbazone and with paraaminosalicylic acid, and with two new paraaminosalicylic acid derivatives, in the treatment of experimental tuberculosis]. names it Schweiz Med Wochenschr 1950
[Activity of thio-semicarbazone in ocular tuberculosis]. names it Minerva Med 1950
[The pulmonary lavage in the diagnosis is thio-pathogenic or evolutionary of tuberculosis]. names it An Paul Med Cir 1946

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

Genomic-neighbour overlap (structural caveat) co-directional · 0 % of gene

NeighbourthiS (Rv0416, + strand)
Overlap4 bp, 0 % of this gene's length

co-directional overlap: ordinary (e.g. shared stop/start codons in an operon), not the Rv2438A-type artefact P20.1, derived from GFF3 gene coordinates, 2026-08-03.

CRISPRi vulnerability

Vulnerability index -7.54 (95% CI -7.78 to -7.29). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Legacy record & comparison (Mycobrowser)

Mycobrowser functionPossibly involved in thiamine biosynthesis.
Mycobrowser EC 1.-.-.- · superseded EC numbering; the atlas uses the current class (1.4.3.19)

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb0423 · 99.7% identity
M. leprae ML0299c · 82.0% identity
M. marinum MMAR_0718 · 84.9% identity
M. smegmatis MSMEG_0791 · 79.3% identity
M. orygis RJtmp_000435 · 100.0% identity
M. abscessus MAB_4218c · 67.4% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt P96261 TrEMBL · unreviewed · Evidence at protein level
UniProt nameglycine oxidase
EC (curated) EC 1.4.3.19

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category E Amino acid transport and metabolism
Preferred namethiO
eggNOG descriptionGlycine oxidase
Orthologous groupCOG0665
EC number EC 1.4.3.19
KEGG orthology K03153
KEGG pathways map00730, map01100

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.458 · purifying
Polymorphic sites (≥ 0.1% of strains) 5 synonymous, 6 missense, 0 nonsense, 0 frameshift

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Bacteria

Genus-wide presence (~53 non-MTBC Mycobacterium) present in 53/53 (100%) · mean identity 85.4% · 4/4 closest MTBAP relatives
conserved across the genus (present in 53/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 9/13 non-Mycobacterium reference genomes (down to Bacteria) · mean identity 46.3%
detected down to outside the phylum (Proteobacteria/Firmicutes controls) — a universally conserved, ancient bacterial gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis) essential

DeJesus 2017 callES · essential
What the call meansessential: insertions absent across the whole ORF
TA sites (Himar1) 12 in the ORF — 12 in the essential state, 0 growth-defect, 0 non-essential, 0 growth-advantage. Saturation 0.000, mean read count 0. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 12 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Chemical-genetic target & druggability (PROSPECT) hypomorph tool strain

This gene is part of the PROSPECT collection of TetON transcriptional-knockdown (hypomorph) strains of essential M. tuberculosis genes, built as a sensitised background for chemical-genetic mechanism-of-action deconvolution. Being in the panel means the gene is an essential / vulnerable target for which a validated knockdown tool strain exists.

Hypomorph strainRv0415-thiO-TetOn18.1 (TetON promoter 18)
Baseline knockdown fitness3.868 median doublings (across 6 screen pool(s)) — fewer doublings = stronger growth defect on knockdown
Used in target deconvolutionyes (informs phenotypic-cluster / MOA assignment)

Panel membership reflects essentiality/vulnerability and the availability of a genetic tool, not a specific molecular function; it never changes the verdict here. Source: Bond AN et al., Nat Commun 2025;16:9673 (doi:10.1038/s41467-025-64662-x); PROSPECT chemical-genetic platform.

Proteomics (mass spectrometry) detected

MS detectiondetected in 10 of 16 independent MS datasets
Integrated abundance20.3 ppm · rank 2336/3519 (33.6th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox) no export signal, no TM helix

Predictionno signal peptide, no TM helix (DeepTMHMM class GLOB)
DeepTMHMM classGLOB

A verified absence of signals, which is not a compartment. No Sec/Tat signal peptide, no transmembrane helix and no lipobox were found on this sequence. The predictor reports topology and export signals; it does not measure where the protein ends up, so this page draws no cytoplasmic conclusion from it. In M. tuberculosis that reservation is not theoretical: the 12 Esx paralogues of this atlas — EsxA/ESAT-6 and EsxB/CFP-10 among them, the best-established secreted proteins of the species — carry this very call, because substrates of the type VII (ESX) secretion system leave no recognisable signal. « Secreted » and « no signal peptide » are true together here.

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length340 aa
Molecular weight36.5 kDa
Theoretical pI6.15
GRAVY0.014 (hydrophobic)
Aliphatic index103.5
Aromaticity0.047
Instability index42.6 (unstable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
DAOPF01266.31 3.7e-5510–329 FAD dependent oxidoreductase

3D structure (interactive — Mol*/pdbe-molstar)

No experimental structure is deposited for this gene: showing the AlphaFold DB predicted model (mean pLDDT 94.6, very high), coloured by per-residue confidence (dark blue = very high, orange/red = low — treat low-confidence regions as unreliable, especially termini and loops). Drag to rotate, scroll to zoom.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 94.6

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
6j39-assembly1_A 1.00 0.84 0.84 0.78 36% 94% / 94% 3.6e-27 sig 6j39-assembly1_A Crystal structure of CmiS2 with inhibitor
6j39-assembly1_B-2 1.00 0.81 0.81 0.77 36% 94% / 93% 8.1e-27 sig 6j39-assembly1_B-2 Crystal structure of CmiS2 with inhibitor
6j38-assembly1_B-2 1.00 0.83 0.83 0.79 34% 97% / 97% 2.0e-26 sig 6j38-assembly1_B-2 Crystal structure of CmiS2
4ysh-assembly1_A 1.00 0.85 0.85 0.78 28% 97% / 96% 1.2e-25 sig 4ysh-assembly1_A Crystal structure of glycine oxidase from Geobacillus kaustophilus
3if9-assembly1_A-2 1.00 0.82 0.82 0.77 26% 95% / 93% 2.3e-24 sig 3if9-assembly1_A-2 Crystal structure of Glycine Oxidase G51S/A54R/H244A mutant in complex with inhibitor glycolate

Foldseek search of the AlphaFold DB model (mean pLDDT 94.6, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon) operon of 3

Upstream (5' on genome)thiE (- strand, 129 bp gap)
Downstream (3' on genome)thiS (+ strand, -4 bp gap)
Predicted operon thiO · thiS · thiG

Neighbours from the H37Rv annotation (+ strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) no multi-gene operon predicted (singleton) — disagrees with the distance heuristic above
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT0428) expressed, no multi-gene operon (exponential phase, coverage 16.03)
expressed, no multi-gene operon (stationary phase, coverage 17.33) — disagrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Transcriptional regulation (signed TRN: ChIP-seq + TFOE)

Regulated by (1 TF) Rv2034 (represses)

Regulatory edges from the ISB signed transcriptional regulatory network (TF ChIP-seq binding, Minch 2015 + TF-overexpression response, Rustad 2014). An edge is regulatory evidence (binding and/or expression change), not necessarily direct. For a "hypothetical", membership in a known regulon (e.g. DosR dormancy, PhoP virulence) is a physiological-context lead, not a function.

Condition: Condition-blind by construction. These edges come from transcription-factor OVEREXPRESSION in a single laboratory condition, so a listed regulator is not a claim that it governs this gene in every circumstance. Measured counter-examples exist within this atlas (see Rv2516c, where the DosR regulon collapses under moxifloxacin while the gene itself rises). Read a regulator as 'capable of shifting this gene', and look for the condition before building a hypothesis on it.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: thiG (thiazole synthase), high confidence (score 1000, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence). The pair is recorded in a curated database (pathway or complex membership) for M. tuberculosis genes themselves (score ≥ 200): a curated association, not a measurement in this organism.

Showing the 15 strongest of this gene's 89 partners at medium confidence (7 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. None of the 89 partners rests on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv0417 thiG curated thiazole synthase 999 1000 ctx neighborhood:881 fusion:838 cooccurence:709 coexpression:461 database:900 textmining:949
Rv0416 thiS sulfur carrier protein ThiS 986 929 ctx neighborhood:881 coexpression:430 textmining:817
Rv0414c thiE thiamine-phosphate synthase 888 873 ctx neighborhood:776 cooccurence:412
Rv0331 exp (transferred) dehydrogenase/reductase 853 834 experimental:821
Rv2211c gcvT exp (transferred) aminomethyltransferase 844 823 experimental:773
Rv3671c marP curated serine protease 627 622 database:549
Rv3339c icd1 curated isocitrate dehydrogenase 619 599 database:576
Rv1872c lldD2 curated L-lactate dehydrogenase 614 590 database:551
Rv0694 mftD curated mycofactocin system heme/flavin oxidoreductase MftD 613 589 database:551
Rv0125 pepA curated serine protease PepA 568 563 database:549
Rv1223 htrA curated serine protease HtrA 567 562 database:549
Rv0983 pepD curated serine protease PepD 567 562 database:549
Rv1043c curated hypothetical protein 564 559 database:549
Rv3672c curated hypothetical protein 562 546 database:524
Rv2609c curated membrane protein 559 543 database:524

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: thiamine biosynthesis oxidoreductase ThiO
  • MTBC0 PGAP product: glycine oxidase ThiO
  • Pfam (hmmscan --cut_ga): DAO PF01266.31 (E=4e-55)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_214929.1)
  • Domains: Pfam-A via hmmscan --cut_ga — DAO (PF01266.31)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG0665
  • Curated reference: UniProt P96261 (TrEMBL, unreviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 94.6)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 89 functional partner(s); context anchor thiG
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Transcriptional regulation: ISB signed TRN — TF ChIP-seq (Minch et al. 2015, doi:10.1038/ncomms6829) + TF overexpression (Rustad et al. 2014, doi:10.1186/gb-2014-15-11-502)
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_000435|Rv0415|thiO
MASDLHTGSLAVIGGGVIGLSVARRAAQAGWPVRVHRSDERGASWVAGGMLAPHSEGWPGEERLLRLGLQSLRLWREGSFLDGLGPQLVTAHESLVVAVDRADVADLRTVADWLSAQGHPVIWESAARDVEPLLAQGIRHGFRAPTELAVDNRALLDALCRDCERLGVRWSSQVSSLSDVDAHTVVIANGIDAPALWPGLPIRPVKGEVLRLRWRPGCMPLPQRVIRARVRGRQVYLVPRSDGVVVGATQYEHGRDTAPVVSGVRDLLDDACTVLPALGEYELAECEAGLRPMTPDNLPLVQRLDSRTLVAAGHGRSGFLLAPWTAEQIVSELVSVGAAS